Nonetheless, it is important to underline that, while it can directly act as an angiogenic factor, IL-17 in combination with IFNγ increases the secretion of potent antiangiogenic factors such as CXCL9 and CXCL10 by cancer cells. The gene discussed is IL17A; the disease is cancer.